Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Clarity Pharmaceuticals Ltd
CU6Current price
7.14 AUD
-0.04 AUD (-0.56%)
Last closed
7.08 AUD
Company
www.claritypharmaceuticals.com
ISIN
AU0000165375
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
2 345 699 537 AUD
Yield for 12 month
+468.92 %
1Y
3Y
5Y
10Y
15Y
CU6
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States. The company's products include SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2; developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. It develops theranostic therapy and imaging products for the treatment of cancer in children and adults. The company was incorporated in 2010 and is based in Sydney, Australia. Address: National Innovation Centre, Sydney, NSW, Australia, 2015
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13.76 AUDP/E ratio
–Dividend Yield
–Current Year
+11 707 203 AUD
Last Year
+9 971 359 AUD
Current Quarter
+3 097 264 AUD
Last Quarter
+3 097 264 AUD
Current Year
+11 551 467 AUD
Last Year
+9 869 094 AUD
Current Quarter
+2 993 578 AUD
Last Quarter
+3 097 264 AUD
Key Figures CU6
1 year
3 years
5 years
10 years
EBITDA
-45 425 707 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.19 %
PEG Ratio
–
Return On Equity TTM
-39.29 %
Wall Street Target Price
13.76 AUD
Revenue TTM
11 707 202 AUD
Book Value
0.48 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
49.7 %
Dividend Yield
–
Gross Profit TTM
9 971 359 AUD
Earnings per share
-0.15 AUD
Diluted Eps TTM
-0.15 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CU6
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CU6
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CU6
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
205.0946
Enterprise Value EBITDA
-0.7791
Price Book MRQ
15.7591
Financials CU6
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CU6
For 52 weeks
1.17 AUD
9.13 AUD
50 Day MA
7.57 AUD
Shares Short Prior Month
–
200 Day MA
5.13 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart